Mindray BeneVision N22 - Nellcor Information; Spo 2 Measurement Limitations

BeneVision N22/N19 Patient Monitor Operator’s Manual 13 - 9
13.9 Nellcor Information
■ Nellcor Patents
This device may be covered by one or more of the following US patents and foreign equivalents: 5,485,847,
5,676,141, 5,743,263, 6,035,223, 6,226,539, 6,411,833, 6,463,310, 6,591,123, 6,708,049, 7,016,715, 7,039,538,
7,120,479, 7,120,480, 7,142,142, 7,162,288, 7,190,985, 7,194,293, 7,209,774, 7,212,847, 7,400,919.
■ No Implied License
Possession or purchase of this device does not convey any express or implied license to use the device with
unauthorized replacement parts which would, alone, or in combination with this device, fall within the scope of
one or more of the patents relating to this device.
SpO2 value is inaccurate 1. Check the patient’s vital signs.
2. Check for conditions that may cause inaccurate SpO
2
readings. For
more information, see
13.3 SpO2 Measurement Limitations.
3. Check the monitor, the SpO
2
module or the MPM for proper
functioning.
Problem Solution